Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
mucopolysaccharidosis ii
MeSH D016532 - mucopolysaccharidosis ii
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D038901:
X-linked mental retardation
0 Companies
0 Drugs
Success rate
D009083:
Mucopolysaccharidoses
0 Companies
0 Drugs
Success rate
D016532:
Mucopolysaccharidosis ii
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Takeda
Idursulfase
Elaprase
2006-07-24
Clinical Trials
Historical Success Rate
Phase 1
100
%
5/5
Phase 2
29
%
4/14
Phase 3
71
%
5/7
Approved:
3
Overall Success rate:
20%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Takeda
Idursulfase
,
Idursulfase beta
,
Ademetionine
,
Octagam
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use